WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005062894) CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/062894    International Application No.:    PCT/US2004/043145
Publication Date: 14.07.2005 International Filing Date: 22.12.2004
IPC:
A61K 31/35 (2006.01)
Applicants: DARPHARMA, INC. [US/US]; 215 Cloister Court, Chapel Hill, NC 27514 (US) (For All Designated States Except US).
FERNANDES, Prabhavathi, B. [US/US]; (US) (For US Only).
MAILMAN, Richard, Bernard [US/US]; (US) (For US Only).
NICHOLS, David, Earl [US/US]; (US) (For US Only).
POSTLETHWAIT, Robert, Neil [US/US]; (US) (For US Only)
Inventors: FERNANDES, Prabhavathi, B.; (US).
MAILMAN, Richard, Bernard; (US).
NICHOLS, David, Earl; (US).
POSTLETHWAIT, Robert, Neil; (US)
Agent: ADDISON, Bradford, G.; Barnes & Thornburg, 11 South Meridian Street, Indianapolis, IN 46204 (US)
Priority Data:
60/532,248 23.12.2003 US
Title (EN) CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS
(FR) CO-ADMINISTRATION DE COMPOSES DE LIAISON AU RECEPTEUR DE LA DOPAMINE
Abstract: front page image
(EN)Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D1 receptor agonist, and administering to the patient an effective amount of a dopamine D2 receptor antagonist. Pharmaceutical compositions comprising a dopamine D1 receptor agonist and a dopamine D2 receptor antagonist are also described. The D1 dopamine receptor agonist and the D2 dopamine receptor antagonist can be administered to the patient in the same or in a different composition or compositions.
(FR)L'invention concerne des méthodes permettant de traiter un patient souffrant de troubles neurologiques, psychotiques et psychiatriques, qui consiste à administrer audit patient une quantité efficace d'un agoniste partiel et/ou total du récepteur D1 de la dopamine, et une quantité efficace d'un agoniste du récepteur D2 de la dopamine. L'invention concerne également des compositions pharmaceutiques comprenant un agoniste du récepteur D1 de la dopamine et un agoniste du récepteur D2 de la dopamine. Ces agonistes peuvent être administrés dans la même composition ou dans des compositions différentes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)